Peripheral neuropathy Board decisions

The Board denied entitlement to evaluations in excess of 10 percent for diabetic neuropathy of the left and right lower extremities involving the femoral nerves prior to April 13, 2022.

The Board granted separate ratings of 20 percent for right and left lower peripheral neuropathy of the deep peroneal nerve effective May 26, 2015, but denied increased ratings in excess of 20 percent for right and left lower extremity peripheral neuropathy of the sciatic nerve.

The Board denied service connection for all claimed conditions as there was no evidence linking them to the Veteran's active duty service.

The Board dismissed all claims for earlier effective dates and increased ratings for service-connected conditions, as well as the claim for service connection for erectile dysfunction, due to the Veteran's death and the fact that no unadjudicated issues were pending at the time of his passing.

The Board remands the claims for service connection for colon cancer, hypertension, diabetes mellitus, vision condition (secondary to diabetes mellitus), erectile dysfunction, headaches, and peripheral neuropathy of the left foot/heel due to a need for additional development, including VA examinations.

The Veteran's generalized anxiety disorder with persistent depressive disorder and alcohol abuse disorder (GAD) is shown to preclude the Veteran from securing and following substantially gainful employment consistent with his work and education background from November 1, 2012.

The Board granted service connection for diabetes mellitus type II, hypertension as secondary to diabetes mellitus type II, and bilateral lower extremity diabetic peripheral neuropathy as secondary to diabetes mellitus type II.

The appeal for service connection and increased ratings was dismissed due to untimely filing of the notice of disagreement.

The Board remands the claims for service connection for bilateral lower extremity peripheral neuropathy to obtain a new medical opinion regarding whether the condition is but-for caused by the Veteran's service-connected disabilities of hypertension and ischemic heart disease.

The Board granted service connection for depressive disorder with anxiety disorder and bilateral lower extremity diabetic neuropathy, atherosclerotic cardiovascular disease, and chronic kidney disease, all secondary to diabetes mellitus. A 30 percent initial rating was granted for stasis dermatitis.

The Board remands the claims for increased ratings for the Veteran's idiopathic neuropathy conditions due to insufficient evidence and the need for a medical opinion on the ameliorative effects of medication.

The Board granted an effective date of July 17, 2020, for the award of service connection for left and right upper extremity idiopathic peripheral neuropathy and lumbosacral strain.

The Board remands the claims for service connection for bilateral lower extremity peripheral neuropathy to obtain an adequate medical opinion addressing the Veteran's claimed disabilities and their potential relationship to his military service, including exposure to herbicidal agents.

The Board denied the veteran's claims for increased ratings for bilateral maxillary sinusitis, right foot sural neuropathy, right fifth metatarsal surgical scar, and GERD.

The Board remands the claims for service connection due to inadequate VA opinions.

The Board denied the veteran's claims for increased ratings and service connection, as well as a TDIU.

The Board granted service connection for alcohol dependence and peripheral neuropathy of the lower extremities, both secondary to service-connected conditions.

The Board granted service connection for hyperthyroidism as secondary to in-service exposure to herbicide agents, and for neuropathy of the right and left lower extremities and right eye exophthalmos and diplopia as secondary to service-connected hypothyroidism.

The Board granted readjudication of the claims for service connection for headaches, a sleep condition (OSA), Parkinsonism (including Parkinson's disease), unspecified depressive disorder, CAD with atrial fibrillation, bilateral upper extremity neuropathy, and bilateral lower extremity neuropathy based on new evidence. The claim for hyperhidrosis was denied as no new relevant evidence was received.

The Board denied the veteran's claims for increased ratings and other benefits due to insufficient evidence of disability severity beyond the current ratings.